Prosecution Insights
Last updated: August 18, 2026
Application No. 18/832,776

Sub-assembly for a medicament delivery device

Non-Final OA §102§103
Filed
Jul 24, 2024
Priority
Jan 28, 2022 — EU 22154031.3 +1 more
Examiner
BRUTUS, JOEL F
Art Unit
Tech Center
Assignee
Shl Medical AG
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
1y 4m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
946 granted / 1303 resolved
+12.6% vs TC avg
Strong +18% interview lift
Without
With
+17.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
38 currently pending
Career history
1344
Total Applications
across all art units

Statute-Specific Performance

§101
7.5%
-32.5% vs TC avg
§103
51.7%
+11.7% vs TC avg
§102
13.7%
-26.3% vs TC avg
§112
20.4%
-19.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1303 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 16, 18-19, 23-24, 26-29 are rejected under 35 U.S.C. 102(a)(b) as being anticipated by Karlsson et al (Pub. No.: US 2018/0104414). Regarding claim 16, Karlsson et al disclose a sub-assembly for a medicament delivery device [see 0059, 0063, 0065]; the sub-assembly comprising: a sub-assembly housing (hollow cylinder 821) extending along a longitudinal axis between a distal end and a proximal end [see 0059], wherein the sub-assembly housing comprises a flexible arm extending in a distal direction of the sub-assembly housing [see 0059, figs 5-6b]; wherein the flexible arm comprises a distally directed flexible arm surface [see 0059]; a rotator (coupling member 84) comprising a support wall extending in the direction of the longitudinal axis [see figs 4-6B]; a plunger rod comprising a proximally directed plunger rod surface adjacent to the distally directed flexible arm surface [see abstract, 0028, 0058-0059]; a biasing member extending in the direction of the longitudinal axis between a proximally directed sub-assembly housing surface of the sub-assembly housing and a distally directed surface of the plunger rod [see 0058-0059]; wherein the rotator (coupling member) is rotatable around the longitudinal axis relative to the sub-assembly housing from a first rotator position where the support wall is adjacent to an outer surface of the flexible arm of the sub-assembly housing to a second rotator position (due to a rotation, emphasis added) where the support wall is circumferentially offset (via alignment, 0077) to the outer surface of the flexible arm [see 0062, 0077]. Regarding claim 18, Karlsson et al disclose wherein the flexible arm extends in the distal direction from the distal end of the sub-assembly housing [see figs 4-6B]. Regarding claim 19, Karlsson et al disclose wherein the rotator is axially immovable (via locking element) relative to the sub-assembly housing [see 0008, 0015]. Regarding claim 23, Karlsson et al disclose wherein the rotator comprises a cylindrical or semi-cylindrical rotator body [see fig 4]. Regarding claim 24, Karlsson et al disclose wherein the actuated surface of the rotator is arranged at the proximal end of the rotator body [see 0062, 0077]. Regarding claim 26, Karlsson et al disclose wherein the plunger rod comprises a rod body, wherein a recess or cut-out is arranged in a sidewall of the rod body, wherein a distal edge of the recess or cut-out defines the proximally directed plunger rod surface [see figs 5A-6B]. Regarding claim 27, Karlsson et al disclose wherein the biasing member is a compression spring surrounding a portion of the rod body of the plunger rod [see figs 5A-6B]. Regarding claim 28, Karlsson et al disclose wherein the sub-assembly housing comprises an inner arm extending from the distal end towards the proximal end of the sub-assembly housing, wherein the inner arm comprises a protrusion radially inwardly extending from a proximal end of the inner arm [see figs 5A-6B]. wherein the plunger rod comprises a radially outwardly extending structure configured to interact with the protrusion of the inner arm when the plunger rod moves past the inner arm [see figs 5A-6B]. Regarding claim 29, Karlsson et al disclose wherein the radially outwardly extending structure of the plunger rod extends from the rod body of the plunger rod, wherein the radially outwardly extending structure has a surface that is perpendicular to the rod body [see figs 5A-6B]. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 17 are rejected under 35 U.S.C. 103 as being unpatentable over Karlsson et al (Pub. No.: US 2018/0104414) in view of Holmqvist et al (Pub. No.: US 2020/0197618). Regarding claim 17, Karlsson et al don’t disclose wherein at least one of the distally directed flexible arm surface of the flexible arm and the proximally directed plunger rod surface of the plunger rod is beveled. Nonetheless, Holmqvist et al disclose wherein at least one of the distally directed flexible arm surface of the flexible arm and the proximally directed plunger rod surface of the plunger rod is beveled [see 0065, claim 19] by disclosing first arm 21b has a first tangential tab 21c having a distal end face 21c which is beveled in the tangential direction [see 0065]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Karlsson et al and Holmqvist et al by using a plunger rod surface of the plunger rod that is beveled; the beveled leading edge prevents abrasive solids (such as sand or fines) from lodging between the plunger and the pump barrel. This design minimizes contact points that would otherwise cause erosion, extending the life of both the plunger and the barrel. Claim(s) 20-21, 25, 30 are rejected under 35 U.S.C. 103 as being unpatentable over Karlsson et al (Pub. No.: US 2018/0104414) in view of Sall (Pub. No.: US 2019/0365999). Regarding claims 20-21, 25, Karlsson et al don’t disclose an actuator surface, wherein the rotator comprises an actuated surface facing towards the actuator surface, wherein at least one of the actuator surface and the actuated surface is helical relative to the longitudinal axis, wherein the actuator surface is configured to move along the actuated surface with a movement of the actuator member relative to the rotator in the direction of the longitudinal axis moving the rotator from the first rotator position to the second rotator position. Nonetheless, Sall discloses an actuator surface, wherein the rotator comprises an actuated surface facing towards the actuator surface, wherein at least one of the actuator surface and the actuated surface is helical (drive spring) relative to the longitudinal axis [see 0063-0065] wherein the actuator surface is configured to move along the actuated surface with a movement of the actuator member relative to the rotator in the direction of the longitudinal axis moving the rotator from the first rotator position to the second rotator position [see 0065-0074] Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Karlsson et al and Sall by using an actuator surface, wherein the rotator comprises an actuated surface facing towards the actuator surface, wherein at least one of the actuator surface and the actuated surface is helical relative to the longitudinal axis, wherein the actuator surface is configured to move along the actuated surface with a movement of the actuator member relative to the rotator in the direction of the longitudinal axis moving the rotator from the first rotator position to the second rotator position; for activation purposes Regarding claim 30, Karlsson et al don’t disclose wherein the medicament delivery device is an autoinjector. Nonetheless, Sall discloses wherein the medicament delivery device is an autoinjector [see 0012]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Karlsson et al and Sall by using an autoinjector; Autoinjectors offer convenience, precision, safety, and improved adherence Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOEL F BRUTUS whose telephone number is (571)270-3847. The examiner can normally be reached Mon-Sat, 11:00 AM to 7:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Kozak can be reached at 571-270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOEL F BRUTUS/ Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Jul 24, 2024
Application Filed
Jul 29, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702490
METHOD FOR IMAGING AN IMPLANTED IMPLANT
2y 11m to grant Granted Aug 11, 2026
Patent 12702328
SYSTEMS AND METHODS FOR HIGH RESOLUTION DISTANCE SENSING AND APPLICATIONS
2y 0m to grant Granted Aug 11, 2026
Patent 12697470
MRI Compatible Interventional Wireguide
1y 9m to grant Granted Aug 04, 2026
Patent 12678126
SAFETY ALERT BASED ON 4D INTRACARDIAC ECHO (ICE) CATHETER TRACKING
1y 8m to grant Granted Jul 14, 2026
Patent 12661499
SENSORS FOR CATHETER PUMPS
1y 11m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
90%
With Interview (+17.9%)
3y 5m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1303 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month